Raymond James & Associates Vascular Biogenics Ltd. Transaction History

Raymond James & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.92 - $2.53 $24,337 - $32,070	-12,676 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$1.69 - $2.67 $1,649 - $2,605	976 Added 8.34%	12,676 $30,000
Q1 2021 May 14, 2021	BUY	$1.79 - $2.91 $1,790 - $2,910	1,000 Added 9.35%	11,700 $23,000
Q4 2020 Feb 12, 2021	SELL	$1.07 - $2.0 $17,708 - $33,100	-16,550 Reduced 60.73%	10,700 $20,000
Q3 2020 Nov 04, 2020	SELL	$1.11 - $1.4 $6,826 - $8,610	-6,150 Reduced 18.41%	27,250 $33,000

Q1 2020 Apr 21, 2020	SELL	$0.96 - $1.57 $960 - $1,570	-1,000 Reduced 2.91%	33,400 $45,000
Q4 2019 Feb 12, 2020	SELL	$1.1 - $1.32 $5,500 - $6,600	-5,000 Reduced 12.69%	34,400 $41,000
Q3 2019 Nov 07, 2019	SELL	$1.11 - $1.42 $16,650 - $21,300	-15,000 Reduced 27.57%	39,400 $53,000
Q4 2018 Feb 11, 2019	SELL	$0.6 - $1.72 $19,645 - $56,316	-32,742 Reduced 37.57%	54,400 $53,000
Q3 2018 Nov 14, 2018	BUY	$1.55 - $2.17 $7,750 - $10,850	5,000 Added 6.09%	87,142 $142,000
Q1 2018 May 14, 2018	BUY	$2.27 - $8.5 $60,554 - $226,746	26,676 Added 48.09%	82,142 $189,000
Q4 2017 Feb 14, 2018	BUY	$5.65 - $9.0 $130,650 - $208,116	23,124 Added 71.5%	55,466 $394,000
Q3 2017 Nov 13, 2017	SELL	$4.15 - $7.2 $33,200 - $57,600	-8,000 Reduced 19.83%	32,342 $197,000
Q2 2017 Aug 14, 2017	BUY	N/A	40,342	40,342 $180,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.